Cargando…

NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas

BACKGROUND: Photodynamic therapy (PDT) subsequent to surgical tumor removal is a novel light-activated localized treatment for malignant glioma. Although PDT provides effective local control, even PDT cannot completely suppress local recurrence of malignant glioma. We previously reported that the ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Yuichi, Nagashima, Hiroaki, Tanaka, Kazuhiro, Hashiguchi, Mitsuru, Itoh, Tomoo, Sasayama, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648157/
http://dx.doi.org/10.1093/noajnl/vdab159.070
_version_ 1784610745156108288
author Fujita, Yuichi
Nagashima, Hiroaki
Tanaka, Kazuhiro
Hashiguchi, Mitsuru
Itoh, Tomoo
Sasayama, Takashi
author_facet Fujita, Yuichi
Nagashima, Hiroaki
Tanaka, Kazuhiro
Hashiguchi, Mitsuru
Itoh, Tomoo
Sasayama, Takashi
author_sort Fujita, Yuichi
collection PubMed
description BACKGROUND: Photodynamic therapy (PDT) subsequent to surgical tumor removal is a novel light-activated localized treatment for malignant glioma. Although PDT provides effective local control, even PDT cannot completely suppress local recurrence of malignant glioma. We previously reported that the acute response of malignant glioma to PDT could be detected as linear hyperintense signals on diffusion-weighted imaging (DWI) and a decline in apparent diffusion coefficient (ADC) values that were asymptomatic and transient. However, their long-term clinical significance has not yet been examined. This study aimed to clarify the link between the hyperintense signal on DWI as an acute response and recurrence after PDT in malignant glioma. METHODS: Thirty consecutive patients (16 men, 14 women; median age 60.5 years) underwent PDT for malignant glioma at our institution between 2017 and 2020. We analyzed signal changes on DWI after PDT and the link between these findings and the recurrence pattern. RESULTS: In all patients, linear hyperintense signals of 5–7 mm on DWI were detected at the surface of the resected cavity from day 1 after PDT. These changes matched the PDT-irradiated area and disappeared in about 30 days without any neurological deterioration. Of the 30 patients, 19 (63%) exhibited recurrence: local recurrence in 10 (33%), distant recurrence in 1 (3%), and dissemination in 8 (27%). All local recurrences arose from areas that did not show a hyperintense signal on DWI obtained on day 1 after PDT. Patients with distant recurrence or dissemination tended to have uninterrupted hyperintense signal on DWI obtained on day 1 after PDT. CONCLUSION: The local recurrence in malignant glioma after PDT occurred in the areas without hyperintense signal on DWI as the acute response to PDT. This characteristic finding could aid in the monitoring of not only PDT-irradiated area but also local recurrence site after PDT.
format Online
Article
Text
id pubmed-8648157
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86481572021-12-07 NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas Fujita, Yuichi Nagashima, Hiroaki Tanaka, Kazuhiro Hashiguchi, Mitsuru Itoh, Tomoo Sasayama, Takashi Neurooncol Adv Supplement Abstracts BACKGROUND: Photodynamic therapy (PDT) subsequent to surgical tumor removal is a novel light-activated localized treatment for malignant glioma. Although PDT provides effective local control, even PDT cannot completely suppress local recurrence of malignant glioma. We previously reported that the acute response of malignant glioma to PDT could be detected as linear hyperintense signals on diffusion-weighted imaging (DWI) and a decline in apparent diffusion coefficient (ADC) values that were asymptomatic and transient. However, their long-term clinical significance has not yet been examined. This study aimed to clarify the link between the hyperintense signal on DWI as an acute response and recurrence after PDT in malignant glioma. METHODS: Thirty consecutive patients (16 men, 14 women; median age 60.5 years) underwent PDT for malignant glioma at our institution between 2017 and 2020. We analyzed signal changes on DWI after PDT and the link between these findings and the recurrence pattern. RESULTS: In all patients, linear hyperintense signals of 5–7 mm on DWI were detected at the surface of the resected cavity from day 1 after PDT. These changes matched the PDT-irradiated area and disappeared in about 30 days without any neurological deterioration. Of the 30 patients, 19 (63%) exhibited recurrence: local recurrence in 10 (33%), distant recurrence in 1 (3%), and dissemination in 8 (27%). All local recurrences arose from areas that did not show a hyperintense signal on DWI obtained on day 1 after PDT. Patients with distant recurrence or dissemination tended to have uninterrupted hyperintense signal on DWI obtained on day 1 after PDT. CONCLUSION: The local recurrence in malignant glioma after PDT occurred in the areas without hyperintense signal on DWI as the acute response to PDT. This characteristic finding could aid in the monitoring of not only PDT-irradiated area but also local recurrence site after PDT. Oxford University Press 2021-12-06 /pmc/articles/PMC8648157/ http://dx.doi.org/10.1093/noajnl/vdab159.070 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Abstracts
Fujita, Yuichi
Nagashima, Hiroaki
Tanaka, Kazuhiro
Hashiguchi, Mitsuru
Itoh, Tomoo
Sasayama, Takashi
NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
title NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
title_full NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
title_fullStr NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
title_full_unstemmed NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
title_short NI-7 Diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
title_sort ni-7 diffusion-weighted imaging for monitoring acute response and recurrence after photodynamic therapy in malignant gliomas
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648157/
http://dx.doi.org/10.1093/noajnl/vdab159.070
work_keys_str_mv AT fujitayuichi ni7diffusionweightedimagingformonitoringacuteresponseandrecurrenceafterphotodynamictherapyinmalignantgliomas
AT nagashimahiroaki ni7diffusionweightedimagingformonitoringacuteresponseandrecurrenceafterphotodynamictherapyinmalignantgliomas
AT tanakakazuhiro ni7diffusionweightedimagingformonitoringacuteresponseandrecurrenceafterphotodynamictherapyinmalignantgliomas
AT hashiguchimitsuru ni7diffusionweightedimagingformonitoringacuteresponseandrecurrenceafterphotodynamictherapyinmalignantgliomas
AT itohtomoo ni7diffusionweightedimagingformonitoringacuteresponseandrecurrenceafterphotodynamictherapyinmalignantgliomas
AT sasayamatakashi ni7diffusionweightedimagingformonitoringacuteresponseandrecurrenceafterphotodynamictherapyinmalignantgliomas